The Botulinum Toxin Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Botulinum Toxin Market:
https://www.thebusinessresearchcompany.com/report/botulinum-toxin-global-market-report
According to The Business Research Company’s Botulinum Toxin Global Market Report 2024, The botulinum toxin market size has grown rapidly in recent years. It will grow from $6.72 billion in 2023 to $7.4 billion in 2024 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to cosmetic applications, medical therapies, growth in aesthetic medicine, increased awareness and acceptance, research and development initiatives.
The botulinum toxin market size is expected to see strong growth in the next few years. It will grow to $10.53 billion in 2028 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to expanding aesthetic medicine market, advancements in formulations and delivery, diversification of therapeutic uses, global aging population, rising demand in emerging markets, growing patient awareness and acceptance, global market expansion. Major trends in the forecast period include strategic collaborations, personalized and precision medicine approaches, regulatory approvals for new indications, product innovations.
The increasing demand for aesthetic procedures is expected to propel the growth of the botulinum toxin market going forward. Aesthetic procedures refer to a range of cosmetic treatments and interventions that are performed to enhance or improve a person’s appearance and can be surgical or non-surgical. Botulinum toxin is used in aesthetic procedures to relax specific muscles and reduce the appearance of wrinkles and fine lines. For Instance, in 2021, According to the statistical report Aesthetic Plastic Surgery published by The American Society for Aesthetic Plastic Surgery, a US-based organization for the advancement of cosmetic surgery, in 2020, the average plastic surgeon performed 220 surgical procedures, however, in 2021, the average number of surgical procedures performed by plastic surgeons increased to 320, indicating a notable rise in surgical activity within the field. Therefore, the increasing demand for aesthetic procedures is driving the growth of the botulinum toxin market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=11884&type=smp
The botulinum toxin market covered in this report is segmented –
1) By Type: Botulinum Toxin Type A, Botulinum Toxin Type B
2) By Application: Therapeutics, Aesthetics
3) By End User: Hospitals, Specialty Clinics, Dermatology Clinics, Other End Users
Product innovations are the key trends gaining popularity in the botulinum toxin market. Companies operating in the botulinum toxin market are innovating products to sustain their position in the market. For instance, in January 2023, Evolus Inc., a US-based medical aesthetics company got approval from the Australian Therapeutic Goods Administration (TGA) for Nuceiva (prabotulinumtoxin A) in Australia. Nuceiva (prabotulinumtoxinA) is a neurotoxin that contains botulinum toxin type A and used for aesthetic purposes. This product is used for temporary improvement of the appearance of moderate glabellar lines in adult patients by blocking the nerve impulses of facial muscles and making them relax and smoothing the wrinkles formed by facial expressions, squinting, and frowning.
The botulinum toxin market report table of contents includes:
1. Executive Summary
2. Botulinum Toxin Market Characteristics
3. Botulinum Toxin Market Trends And Strategies
4. Botulinum Toxin Market – Macro Economic Scenario
5. Global Botulinum Toxin Market Size and Growth
.
.
.
26. South America Botulinum Toxin Market
27. Brazil Botulinum Toxin Market
28. Middle East Botulinum Toxin Market
29. Africa Botulinum Toxin Market
30. Botulinum Toxin Market Competitive Landscape And Company Profiles
Top Major Players:
- Cigna Group
- Pfizer Inc
- AbbVie Inc.
- Teijin Pharma Ltd
- Eisai Co. Ltd
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
